Open post

Boehringer Ingelheim joins the TransQST consortium

Boehringer Ingelheim has joined the consortium, effective since July 2017

The Boehringer Ingelheim (BI) pharmaceutical company made a formal proposal to join the TransQST consortium in June 2017. The TransQST partners found their addition to be an excellent opportunity to complement and extend the coverage of the modeling framework within the particular area of GI toxicity assessment (WP8). SYNAPSE has coordinated the documentation preparation between […]

Read moreMore Tag
Open post

Kick off meeting

TransQST kick off Meeting was held in Barcelona (Spain) in January 2017

The Kick off Meeting of the TransQST project took place on the 23rd and 24th of January 2017 in the city of Barcelona, and counted with the attendance of the representatives of the whole Consortium. The new European five-year research project, Translational Quantitative Systems Toxicology to improve the understanding of the safety medicines (TransQST), was launched […]

Read moreMore Tag
Open post

News Release

€16M cash boost for adverse drug reaction research

A new European research project has been launched which aims to improve the understanding of adverse drug reactions (ADR) and the approach of systems modelling approaches to drug safety. A new €16m European research project has been launched which aims to improve the understanding of adverse drug reactions and the approach of systems modelling approaches […]

Read moreMore Tag